摘要
肺炎链球菌疫苗仍是全球最急需的前3位疫苗之一,为保证一个最佳的肺炎链球菌多糖菌苗和(或)蛋白多糖结合菌苗复合物,很有必要对肺炎链球菌进行菌型监测。近年来,WHO及许多国家开展了肺炎链球菌的菌型监测,取得了较好的进展,其分型方法也在不断改进。
参考文献20
-
1Lund E. Bull WHO, 1960; 23: 5
-
2Butler JC. Microb Drug Resist, 1997;3(2): 125-129
-
3Rudolph KM et al. J Infect Dis, 2000; 182(2) : 490-496
-
4Lovgren M et al. CMAJ, 1998; 158(3) :327-331
-
5Song JH et al. Clin Infect Dis,1999; 28(6): 1206-1211
-
6Soh SWL et al. Antimicrob Agents Chemother, 2000;44(8) : 2193-2196
-
7Soewignjo S et al.Clin Infect Dis, 2001; 32(7) : 1039-1043
-
8Chiou CC et al. J Clin Microbiol, 2001;39(3) : 1144 -1147
-
9Lathin MK. Bull WHO, 1996; 74(4): 387-390
-
10Lalitha MK et al. J Clin Microbiol, 1999; 37(1):263 - 265
同被引文献37
-
1熊亚莉,范昕建.青霉素结合蛋白研究进展[J].国外医药（抗生素分册）,2004,25(5):193-197. 被引量：12
-
2Balakrishnan I, Crook P, Morris R, et al. Early predictors of mortality in pneumococcal bacteraemia[ J]. J Infect, 2000, 40 (3) : 256 -261.
-
3Luby S P, Brooks W A, Saha S K, et al. Use of multiple surveillance modalities to assess the epidemiology of Streptococcus pneumoniae infection in Bangladesh[J]. Clin Infect Dis, 2009, 48(Suppl 2) : S97 -S102.
-
4Jacobs M R. Streptococcus pneumoniae: epidemiology and patterns of resistance[J]. Am J Med, 2004, 117(Suppl 3A) : 3S - 15S.
-
5Shapiro E D, Berg A T, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine [ J ]. N Engl J Med, 1991 , 325(21 ) : 1453 - 1460.
-
6WHO. Pneumococcal conjugate vaccine for childhood immunization-- WHO position paper[J].Wkly Epidemiol Rec, 2007, 82( 12): 93 -104.
-
7De-Roux A, Schmole-Thoma B, Siber G, et al. Comparison of pneumococcal conjugate poiysaccharide and free polysaccharide vaccines in elderly aduhs: conjugate vaccine elicits improved antibacterial immune responses and immunological memory [J]. Clin Infect Dis, 2008, 46(7) : 1015 - 1023.
-
8Bogaert D, De-Groot R, Hermans P W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease[J].Lancet Infect Dis, 2004, 4(3): 144- 154.
-
9Lu Y J, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization [J].PLoS Pathog, 2008, 4 (9) : e1000159.
-
10Ferreira D M, Darrieux M, Oliveira M L, et al. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is charaeterized by a balanced immunoglobulin G1 (IgG1)/ IgG2a ratio and proinflammatory cytokine production [ J ]. Clin Vaccine lmmunol. 2008, 15 ( 3 ) : 499 - 505.
引证文献3
-
1王晔.肺炎链球菌对青霉素耐药性的研究进展[J].实用临床医学（江西）,2005,6(9):146-147. 被引量：3
-
2姚润,姜学美,闫文娟,王虹,张雪梅.热灭活疫苗HID39免疫小鼠可抵抗肺炎链球菌感染[J].第三军医大学学报,2011,33(5):485-488.
-
3张永茂,贾肇一,王颖童,何宝花,孙印旗.肺炎链球菌脉冲场凝胶电泳分型分析方法的建立与优化[J].医学动物防制,2022,38(9):915-918.
-
1李马超,任红宇,朱兵清,邵祝军.241株肺炎链球菌血清分型及耐药性研究[J].中国疫苗和免疫,2013,19(4):336-340. 被引量：3
-
2任红宇,王晓蕾,李马超,张砺,高源,邵祝军.123株肺炎链球菌血清分型及耐药性研究[J].中国疫苗和免疫,2010,16(1):52-55. 被引量：7
-
3王立亚.肺炎链球菌及其多糖菌苗[J].微生物学免疫学进展,1990,18(3):86-95.
-
4肖素坤,赵春江,刘春林,王辉.我国成人和儿童中分离的肺炎链球菌的耐药性与血清型研究[J].中华结核和呼吸杂志,2010,33(8):601-607. 被引量：32
-
5丁绍卿,叶人邦,袁曾麟.肺炎链球菌血清学分型的研究[J].中国生物制品学杂志,1988,1(1):18-22. 被引量：5
-
6张雪华.2004—2009年益阳市中心医院临床分离肺炎链球菌的血清型/群分布及耐药性监测[J].药物评价研究,2011,34(2):101-104. 被引量：1
-
7王亲民.结合菌苗的免疫学特征[J].微生物学免疫学进展,1992,20(3):11-13.
-
8王亲民,王秉瑞.结合菌苗设计要素概述[J].微生物学免疫学进展,1991,19(4):10-16.
-
9秦敏,栗克喜.伤寒沙门氏菌Vi多糖菌苗的研制[J].生物制品资料选编,1990(14):20-23.
-
10徐葛林.b型流感杆菌结合菌苗在婴幼儿中的应用[J].国外医学（预防．诊断．治疗用生物制品分册）,1993,16(4):157-158.
